音飞储存：2025年前三季度净利润约6241万元

Group 1 - The company reported a revenue of approximately 688 million yuan for the first three quarters of 2025, representing a year-on-year decrease of 23.74% [1] - The net profit attributable to shareholders of the listed company was about 62.41 million yuan, a year-on-year decline of 41.19% [1] - The basic earnings per share were 0.2121 yuan, down 41.2% compared to the previous year [1] Group 2 - The Chinese innovative drug sector has sold overseas authorizations worth 80 billion USD this year [1] - There is a contrast in the biopharmaceutical secondary market being active while the primary market is facing challenges in fundraising [1]